Age Group
	Patients With Newly Diagnosed HIV-⁠1		Patients Initiated With PrEP
	10-17 y	18-64 y	10-17 y	18-64 y
Total No. of patients	220	18 154	175	34 123
Length of follow-⁠upa (mo), mean (SD)	20.9 (15.7)	17.8 (15.1)	18.4 (14.6)	16.8 (14.1)
All-cause healthcare resource utilization
Patients with ≥1 admission/visit, n (%)
Inpatient hospitalization	27 (12.3)	4106 (22.6)	44 (25.1)	2324 (6.8)
ED visit	74 (33.6)	5386 (29.7)	73 (41.7)	6072 (17.8)
Office visit	206 (93.6)	17 028 (93.8)	156 (89.1)	29 413 (86.2)
Outpatient encounterb	215 (97.7)	17 707 (97.5)	157 (89.7)	30 331 (88.9)
Pharmacy prescriptions	173 (78.6)	16 030 (88.3)	175 (100.0)	34 118 (100.0)
No. of admissions/visits PPPM, mean (SD)
Inpatient hospitalization	0.01 (0.06)	0.02 (0.09)	0.03 (0.07)	0.01 (0.05)
ED visit	0.04 (0.07)	0.04 (0.08)	0.07 (0.10)	0.02 (0.06)
Office visit	0.40 (0.35)	0.62 (0.60)	0.60 (0.57)	0.52 (0.49)
Outpatient encounterb	2.29 (2.61)	4.37 (6.18)	2.53 (2.12)	3.09 (3.12)
Pharmacy prescriptions	0.65 (0.90)	1.71 (1.91)	1.47 (1.50)	1.68 (1.57)
HIV-related healthcare resource utilization
Patients with ≥1 admission/visit, n (%)
Inpatient hospitalization	11 (5.0)	1774 (9.8)	NA	NA
ED visit	21 (9.5)	1855 (10.2)	NA	NA
Office visit	75 (34.1)	9159 (50.5)	NA	NA
Outpatient encounterb	185 (84.1)	15 817 (87.1)	NA	NA
Pharmacy prescriptions	34 (15.5)	6708 (37.0)	NA	NA
No. of admissions/visits PPPM, mean (SD)
Inpatient hospitalization	0.004 (0.02)	0.01 (0.06)	NA	NA
ED visit	0.01 (0.03)	0.01 (0.04)	NA	NA
Office visit	0.06 (0.15)	0.15 (0.26)	NA	NA
Outpatient encounterb	0.65 (1.32)	1.29 (2.26)	NA	NA
Pharmacy prescriptions	0.14 (0.38)	0.34 (0.51)	NA	NA